205 related articles for article (PubMed ID: 30556274)
1. Role of the transforming growth factor-β signaling pathway in the pathogenesis of colorectal cancer.
Soleimani A; Pashirzad M; Avan A; Ferns GA; Khazaei M; Hassanian SM
J Cell Biochem; 2019 Jun; 120(6):8899-8907. PubMed ID: 30556274
[TBL] [Abstract][Full Text] [Related]
2. The Role of TGF-β Signaling Regulatory MicroRNAs in the Pathogenesis of Colorectal Cancer.
Moradi-Marjaneh R; Khazaei M; Ferns GA; Aghaee-Bakhtiari SH
Curr Pharm Des; 2018; 24(39):4611-4618. PubMed ID: 30636580
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer.
Khoshakhlagh M; Soleimani A; Binabaj MM; Avan A; Ferns GA; Khazaei M; Hassanian SM
Biochem Pharmacol; 2019 Jun; 164():17-22. PubMed ID: 30905655
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion molecule Kindlin-1 mediates activation of TGF-β signaling by interacting with TGF-βRI, SARA and Smad3 in colorectal cancer cells.
Kong J; Du J; Wang Y; Yang M; Gao J; Wei X; Fang W; Zhan J; Zhang H
Oncotarget; 2016 Nov; 7(46):76224-76237. PubMed ID: 27776350
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta signaling alterations and susceptibility to colorectal cancer.
Xu Y; Pasche B
Hum Mol Genet; 2007 Apr; 16 Spec No 1(SPEC):R14-20. PubMed ID: 17613544
[TBL] [Abstract][Full Text] [Related]
6. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
[TBL] [Abstract][Full Text] [Related]
7. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
[TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen interacts with TGF-{beta} receptor and inhibits TGF-{beta} signaling in colorectal cancers.
Li Y; Cao H; Jiao Z; Pakala SB; Sirigiri DN; Li W; Kumar R; Mishra L
Cancer Res; 2010 Oct; 70(20):8159-68. PubMed ID: 20889724
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.
Ilyas M; Efstathiou JA; Straub J; Kim HC; Bodmer WF
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3087-91. PubMed ID: 10077641
[TBL] [Abstract][Full Text] [Related]
10. TGF-β: an emerging player in drug resistance.
Brunen D; Willems SM; Kellner U; Midgley R; Simon I; Bernards R
Cell Cycle; 2013 Sep; 12(18):2960-8. PubMed ID: 23974105
[TBL] [Abstract][Full Text] [Related]
11. Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.
Jung B; Staudacher JJ; Beauchamp D
Gastroenterology; 2017 Jan; 152(1):36-52. PubMed ID: 27773809
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
Itatani Y; Kawada K; Sakai Y
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
[TBL] [Abstract][Full Text] [Related]
14. TGF-β signaling in cancer.
Gu S; Feng XH
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
[TBL] [Abstract][Full Text] [Related]
15. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
[TBL] [Abstract][Full Text] [Related]
16. Soluble transforming growth factor beta type II receptor attenuates TGF-beta1 activity in human colorectal cancer LoVo cells.
Zhou R; Xiong B; Song H; Liu S; Wang X
Oncol Rep; 2008 Dec; 20(6):1449-56. PubMed ID: 19020727
[TBL] [Abstract][Full Text] [Related]
17. Tgf-beta signaling alterations and colon cancer.
Bellam N; Pasche B
Cancer Treat Res; 2010; 155():85-103. PubMed ID: 20517689
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the functional landscape and therapeutic implications of noncoding RNAs in the TGF-β signaling pathway in colorectal cancer: A comprehensive review.
Saadh MJ; Allela OQB; Sattay ZJ; Al Zuhairi RAH; Ahmad H; Eldesoky GE; Adil M; Ali MS
Pathol Res Pract; 2024 Mar; 255():155158. PubMed ID: 38320438
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Smad3 phosphoisoform-mediated signaling in the development of colonic cancer in IL-10-deficient mice.
Hachimine D; Uchida K; Asada M; Nishio A; Kawamata S; Sekimoto G; Murata M; Yamagata H; Yoshida K; Mori S; Tahashi Y; Matsuzaki K; Okazaki K
Int J Oncol; 2008 Jun; 32(6):1221-6. PubMed ID: 18497983
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
